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CHRONIC EXPOSURE TO OPIOIDS DOWN-REGULATES GENOMIC 
HISTONE MODIFICATIONS AND DISRUPTS STAT3 GENE EXPRESSION IN 
HUMAN INDUCED PLURIPOTENT STEM CELLS 
 
Anirudh Jagannadh Chintalapati 
 
 
Examining epigenetic (EG) manifestations and genomic heterogeneity is a novel 
perspective to understand opioid induced toxicity. Aberrations in histone protein post-
translational modifications (HP-PTM) induce perturbations in chromatin integrity 
resulting in consequences for genomic expression patterns. In the current study, we 
hypothesize that chronic exposure to morphine sulfate (MS) alters histone-3-protein 
(H3)-PTM and disrupts STAT3 gene expression in human induced pluripotent stem cells 
(iPSC). We analyzed 21 genomic H3-PTM following exposure to 1 and 10 M MS for 2 
and 5 days. The results showed decreases in levels of repressive H3-PTM, namely 
H3K9me1 (2 day) and H3K27me3 (5 day). To confirm if these changes were reversible, 
cells were allowed to recover for 3 days in the absence of MS; genomic levels of both 
H3K9me1 and H3K27me3 rebounded to control levels, suggesting that MS induced EG 
effects are reversible and not heritable. Additionally, decreases in levels of H3K9me1 and 
H3K27me3 were concentration dependent and were not antagonized by pre-exposure of 
iPSC to naltrexone indicating that EG effects are independent of opioid receptor 
antagonism. Continuous chronic MS exposure for through 10 passages rendered the 
levels of histone modifications to increase by day 26. In addition, exposure for 2 days 
resulted in significant up-regulation of STAT3 gene expression which plunged with 




translational downregulation of STAT3 demonstrates the ability of MS mediated gene 
expression disruption. Interestingly, STAT3 protein levels remained at control levels 
when iPSC were pretreated with naltrexone prior to MS exposure. Controlled regulation 
of STAT3 signaling pathway is pivotal in sustaining and propagating pluripotency 
phenotype in stem cells. Furthermore, the levels of phosphorylated STAT3 at residues –
tyrosine705 (STAT3-pTyr-705) and –serine727 (STAT3-pSer-727) were down-regulated 
on day 5 and day 2, correspondingly, following MS exposure.  Together, the results 
indicate that MS alters pre-programmed genomic H3-PTM and induces STAT3 gene 
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1.1. Opioids, Opioid Abuse and Addiction, and Morphine Sulfate 
1.1.1. Opioids 
 
Opiates and Opioids are a class of chemically related compounds that elicit their effects by 
binding to endogenous opioid receptors on the cell membrane. Opiates are naturally 
produced opium alkaloids obtained from poppy plant, Papaver somniferum; these include 
morphine, codeine, narcotine, thebaine, papaverine and narceine. The opium latex is 
generally present in differential quantities throughout the plant, but, it is concentrated in 
the developing fruit, serving an evolutionary purpose of protecting seeds (Kreek, 1996). 
The term opioid in general encompass all semi-synthetic and fully synthetic opioid drugs 
such as fentanyl, oxycodone, hydrocodone etc. Endogenous opioids produced naturally in 
the body are classified into 3 families: -endorphin, enkephelin, and dynorphin families, 
that regulate the pathways for autonomic control, pain sensitivity and modulation, reward, 
and stress responses in central and peripheral nervous system (Table 1) (Shenoy & Lui, 
2019).  
1.1.2. Opioid Abuse and Addiction 
 
The advent of malicious opioid crisis inflicts a burden on mankind, often rendering 
clinicians an intractable challenge to mitigate the exponential spread of the opioid epidemic 
(Skolnick, 2018). Abuse and addiction to a prescription opioid pain reliever stems from its 
potential to cause immediate dependency upon short-term use and misuse. In addition, 
illicit and clandestine circulation of heroin, an illegal semi-synthetic prodrug of morphine, 




form of white or brown powder, can be snorted or smoked, thus eliminating the injection 
drug abuse stigma to new users. Prescription opioid use and heroin abuse are inextricably 
related; data pooled from 2002 to 2012 suggests the incidence of heroin abuse being 19 
times higher in population with prior opioid pain reliever use (Powell et al., 2020). 
Furthermore, results from a study conducted among young, injection drug users during 
years 2008 and 2009 demonstrate that 86% of heroin abusers had a usage history of non-
medical opioid pain relievers (Lankenau et al., 2012). The primary factors contributing to 
rapid spread of the opioid epidemic in the U.S. is increased and the ease in availability of 
prescription opioid and under the table heroin. The rate of opioid prescriptions dispensed 
from U.S. pharmacies have increased from 76 to 219 million prescriptions from 1991 to 
2011 (Toth et al., 2016). The Mexican heroin production increased from an estimated 8 
metric tons to 50 metric tons from 2005 to 2009. In order to address such progressive and 
swift spread of opioid epidemic and its associated detrimental consequences to human 
health, it is important to understand the sub-cellular perturbations induced following opioid 
administration. 
1.1.3. Morphine  
 
Archeological evidence demonstrates the cultivation of opium poppies during the Neolithic 
and Bronze eras for its medicinal and pleasuring properties; pointing its likely origination 
to northeastern part of the Mediterranean in Asia minor and Turkey. Evidence also 
indicates that opium was brought into India and China by Arab traders from which it 
travelled all the way to Europe and flourished throughout the world. Morphine, opium’s 
active ingredient was first isolated in 1806 by Wilhelm Serturner, who named it 




morphine’s chemical formula was elucidated by Sir Robert Robinson, for which he was 
awarded the 1947 Noble Prize in Chemistry. 
 Morphine is an alkaloid and a weak base that exerts its pharmacological effect 
primarily through activation opioid receptors (ORs), mu-, kappa-, and delta-opioid 
receptors (OPRM1, OPRK1, and OPRD1, respectively), which are members of the Gi 
protein-coupled receptor (GPCR) superfamily (Kieffer, 1995). However, morphine’s 
analgesic effect is mediated predominantly via OPRM1. After binding to an agonist, the 
ORs activate intracellular signaling through inhibitory G proteins, which affect several 
downstream signaling pathways, including inhibition of adenylyl cyclase and voltage-
gated calcium channels, and activation of receptor-regulated potassium channels (Law et 
al., 2000). These intracellular changes cause hyperpolarization in cells, inhibiting both 
transmission of nerve impulses and release of excitatory neurotransmitters. Although 
morphine and other opioids are used for management of chronic pain conditions, they have 
an enormous potential for abuse. Predisposition to morphine abuse and its addictive 
potential are a direct consequence of its ability to induce tolerance, desensitization, and 
withdrawal (Hyman et al. 2001). In this study, morphine sulfate pentahydrate was used to 
study the effects of opioids when exposed to stem cells (Figure 1). 
1.2. Epigenetics 
 
Epigenetic (EG) mechanistic changes comprise any and all reversible changes in gene 
expression pattern without any modification to the DNA sequence. It is well established 
that EG regulation along with genetic regulation is fundamental to establish, maintain, and 




EG modulations are associated with regulation of cellular plasticity during the processes 
of cellular proliferation, de-differentiation, and homeostasis. EG mechanisms at the 
interface of environment and genome, translate the environmental cues to controlled 
phenotypic changes by altering the dynamic states of chromatin integrity (Mohn & 
Schübeler, 2009). Perturbations in the chromatin landscape results in alterations of gene 
expression pattern in the form of transcriptional activation or repression. EG-mediated 
changes in chromatin structure occurs by 3 distinct yet interrelated pathways: (1) post-
translational modifications (PTM) of histone proteins (HP), (2) covalent addition of methyl 
group to carbon-5 (C-5) of cytosine molecule, referred to as DNA methylation, and (3) 
non-coding RNAs (ncRNAs). It is important to note that EG alterations are not always 
isolated and independent molecular events, but are interrelated, interact, and influence (the 
“3i’s) each other to variable magnitude. For instance, the methyl-CpG binding domain 
(MBD) that binds to CpG regions on DNA containing methyl groups is dependent on the 
chromatin microenvironment regulated by PTM to HP (HP-PTM).  Another example of 
such EG pathway dependency is when methylation of the lysine (K)-4 residue of histone 3 
(H3) serves as a docking site for DNA methyltransferases (DNMTs), causing 
transcriptionally repressive DNA methylation to occur (Li et al., 2011). Interestingly, EG 
pathways demonstrate differential tissue specificity due to differences in expression of EG 
modifiers between tissues (Eckmann-Scholz et al., 2012). EG “modifiers” are the group of 
transcription factors and enzymes that regulate induction or repression of specific EG 
modification. “Readers” are EG modifiers that recognize an EG change in the genome. 
Enzyme modifiers that induce molecular EG changes are referred to as “writers” and 





1.2.1. DNA methylation 
 
DNA methylation is a transcriptionally repressive EG modification that switches 
euchromatin to heterochromatin making DNA unavailable for transcriptional machinery 
binding. Cytosine-guanine dinucleotide (CPG) islands are primary targets for this EG 
modification. DNA methyl transferases (DNMTs) are the enzymes that catalyze this 
reaction by substituting the hydrogen with a methyl group on position 5’ of the pyrimidine 
ring of the cytosine molecule (Chintalapati & Barile, 2019). DNA methyltransferase-1 
(DNMT1), DNA methyltransferase-2 (DNMT2), DNA methyltransferase-3a (DNMT3a) 
and DNA methyltransferase-3b (DNMT3b) are the most commonly recognized 
mammalian DNA methyltransferases. Hemi-methylated DNA is the target of DNMT1, 
known as maintenance methyltransferase and DNMT3a/3b are responsible for de novo 
methylation called de novo methyltransferases. In mammals, the most aggressive 
modulation in DNA methylation associated chromatin dynamics occurs at early stages of 
life. Case in point, the embryonic stage of fetal development is characterized by excessive 
de novo methylation followed by progressive demethylation in the latter stages (Smith & 
Meissner, 2013). This phenomenon of variable methylation is supported by studies 
showing over expression of DNMT3a and 3b at early post-implantation stage of fetal 
development, followed by their immediate decrease in expression in the later stages of 







1.2.2. Post-translational Modifications of Histone Protein 
 
HP-PTM are one of the EG mechanistic subtypes involved in modulating the dynamic 
states of chromatin and consequent gene expression aberrations. PTM alter stability of 
nucleosomal framework in chromatin by modifying the chemical interactions between 
DNA and HP via chemical modifications of several amino acid residues, specifically lysine 
(K) in HP. HP-PTM include wide array of functional group additions and deletions on K-
residues; the most commonly studied K-modifications include methylation, acetylation, 
phosphorylation, ubiquitination, sumoylation and ADP-ribosylation  (Gadhia et al., 2015; 
Chintalapati & Barile, 2019). Despite possible occurrence of PTM on one, few or all HPs, 
H2A, H2B, H3 and H4, H3 modifications are widely supported to have substantial impact 
on gene expression regulation (Herz et al., 2014; Yang et al., 2012). Furthermore, 
methylation of K-residues 4, 9, 27 and 79, and acetylation of K-residues 9, 14, 18, and 56, 
are considered to be of considerable importance in transcriptional initiation, maintenance, 
and termination, collectively called gene activation, and transcriptional repression that 
functionally results in gene inactivation (Kaliman et al., 2014; Lawrence et al., 2016; 
Schvartzman et al., 2018). Evidence suggests acetylation at H3K4 and methylation at 
H3K4, H3K36 and H3K79 are predominantly localized in vicinity of genes undergoing 
active transcription. Conversely, methylation at H3K9, H3K20 and H3K27 are confined to 
regions of transcriptional repression (Hyun et al., 2017; Nguyen et al., 2015; Siveen et al., 
2014; Zhang & Liu, 2015). However, emerging studies indicate the paradoxical presence 
of HP-PTM such as methylated H3K9 in both active and inactive gene expression sites 
(Chintalapati & Barile, 2019; Lawrence et al., 2016). It is important to note that HP-PTM 




and erasers-enzymes that remove a PTM (Biswas & Rao, 2018; Yang et al., 2016; Gadhia 
et al., 2015). Hence, HP-PTM and their influence on genomic expression are the 
determinants of active/inactive gene expression which is in turn influenced by PTM 
localized at the writer and eraser gene regions.  
  
1.2.3. Non-coding RNA 
 
Approximately 2% of human genome constitutes the functional protein coding region; the 
remaining genomic region, historically considered to be superfluous information that code 
non-translatable RNA are referred to as ncRNAs (Wu et al., 2013). However, recent studies 
demonstrate biological significance of ncRNAs which are categorized as small and long 
ncRNAs based on their sequence length. Furthermore, small ncRNAs are further classified 
as microRNAs (miRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), 
piwi-interacting RNAs (piRNAs), transfer RNAs (tRNAs), and small interfering RNAs 
(siRNAs). miRNAs and long ncRNAs are the ncRNAs most studied for their genomic and 
epigenomic influence in living organisms, especially mammals (Chintalapati & Barile, 
2019; Quinn & Chang, 2016). The regulatory function of  ncRNAs involve their interaction 
and complex formation to functional mRNA or other proteins that belong to transcriptional 
machinery causing perturbations in genomic expression.  The mature miRNA elicits its 
influence on functional protein synthesis by recognizing, targeting and complex formation 
with functional mRNA, rendering it ineffective to undergo translation (Kumarswamy et 





1.2.4. Significance of EG modifications as biomarkers in Current Study 
 
The field of EG is now associated with an abundance of biomarkers, and the 
mechanisms of diseases have been correlated to them. Consequently, such EG biomarkers 
offers significant opportunities to understand the progression of pathologies and disease 
states. The role of biomarkers thus encourages appreciation of the mechanisms associated 
with the disease states, aids in the diagnosis of pathologies, and is involved in identifying 
therapeutic modalities with pathological consequences. In vitro and in vivo laboratory 
studies pertaining to opioid induced EG mechanistic perturbations will help identify and 
validate molecular EG biomarkers associated to opioid abuse, addiction, and other 
associated pathological states (Heard & Martienssen, 2014; Sharma, 2017).Recently, abuse 
of opioids and other drugs and their associated molecular EG changes are proving to be 
vital in addiction research (Cadet et al., 2016). However, most of the past and current 
studies pertaining EG’s of opioid addiction were specifically targeted to opioid induced 
cellular changes at the level of developing and/or mature central nervous system circuitry 
and physiology in vivo  (Lester et al., 2011) . Consequently, our current study intends to 
address the potential of opioids to cause aberrations in genomic HP-PTM in induced 
pluripotent stem cells (iPSC) in vitro. Identification and validation of changes in 
biologically significant H3-PTM in response to opioid exposure can serve as valuable EG 
biomarkers for opioid abuse and addiction disease.  The genotypic and phenotypic 
characteristics of iPSC involving substantial EG reprogramming with dynamic chromatin 
remodeling guiding their ability to differentiate into any or all cells of the three embryonic 
layers, ectoderm, endoderm, and mesoderm, render them ideal for EG mechanistic studies 




aberrations in genomic levels of one or multiple H3-PTM in iPSC following acute and 
chronic exposure to MS. 
 
1.3. Signal Transducers and Activators of Transcription  
 
The signal transducers and activators of transcription (STAT) are a class of transcriptional 
factors comprising STAT proteins-1,2,3,4,5a,5b and 6 which participate in cytokine-
mediated cellular signaling (Yu et al., 2014). Among other STAT sub-types, STAT3, an 
acute phase response factor, is considered to be a key biological regulator of cellular 
proliferation, survival, and angiogenesis (Haghikia et al., 2014; Siveen et al., 2014). 
Activation of STAT3 is mediated primarily by IL-6 family of cytokines via janus kinases 
(JAKs), and receptor or non-receptor tyrosine kinases. The kinase-mediated 
phosphorylation of –tyrosine705 (STAT3-pTyr-705) at C-terminal domain, results in 
formation of homodimers or heterodimers with STAT1 resulting in consequent nuclear 
translocation and transcriptional regulation. Additionally, phosphorylation of STAT3 at 
another residue in C-terminal domain –serine727 (STAT3-pSer-727), further strengthens 
STAT3 activation and increases its retention time in nucleus extending the influence on 
genomic transcription (Betts et al., 2015; Zhang et al., 2020). In addition to opioid 
associated G-protein coupled receptor (GPCR) pathway, studies show morphine induced 
stimulation of STAT3 signaling pathway. Evidence suggests that morphine induced 
stimulation to STAT3 signaling is linked to increased proliferation of mesangial cells in 





1.4. Induced Pluripotent Stem Cells (iPSC) 
 
Stem cells generated from mature somatic cells by introducing defined set of transcription 
factors that render pluripotency, self-renewal, and undifferentiated phenotype, are called 
induced pluripotent stem cells (iPSC). IPSC have an in vitro significance unparalleled to 
any mammalian cell line, considering their ability to propagate undifferentiated for several 
passages and can be stimulated to differentiate into many cell types. Mouse iPSC were 
discovered and developed in 2006 by Japanese stem cell researchers Shinya Yamanaka and 
Kazutoshi Takahashi using retrovirus-mediated delivery of four reprogramming 
transcription factors, Oct 3/4 (Octamer-binding transcription factor-3/4), Sox2 (Sex-
determining region Y)-box 2, Klf4 (Kruppel Like Factor-4), and c-Myc, into mouse 
fibroblast cells. Consequently, in 2007, Yamanaka and his team applied a similar 
reprogramming method to adult human fibroblasts to generate human iPSC.  IPSC are used 
for a range of applications including, but not limited to, regenerative medicine, in vitro 
disease modeling, and pharmacological and toxicological screening (Takahashi et al., 
2007).   
 
1.5. Current Study 
        
In mouse embryonic stem cells (mES cells), we previously demonstrated that exposure of 
morphine sulfate (MS) at early and late stages of differentiation leads to down-regulation 
of neuronal phenotype and expression of opioid receptors (Dholakiya et al., 2016). Also, 
we established the occurrence in mitotic inheritance of HP-PTM H3K27me1, and resulting 




the current study we hypothesize that short- and long-term exposure of iPSC to MS induces 
heritable EG aberrations to genomic H3-PTM, H3K9me1 and H3K27me3, and disrupts 
gene expression of critical cell signaling molecule STAT3. This study includes, 
investigating the effects of MS exposure on the levels of genomic H3-PTM, H3K9me1 and 
H3K27me3-; gene expression and protein level aberrations of STAT3, STAT3-pSer-727 
and STAT3-pTyr-705; gene expression changes of OR’s, OPRM1; OPRD1; OPRK1- in 
iPSC. In addition, we concurrently monitored the levels of stem cell specific nuclear 
transcription factor, OCT4 and cell surface marker TRA-1-60 to investigate the influence 





















2. MATERIALS AND METHODS 
2.1. Cell Culture 
 
Undifferentiated episomal human iPSC line derived from CD34+ cord blood 
(Gibco) was maintained on Geltrex LDEV-free reduced growth factor basement membrane 
matrix in serum-free Essential 8TM (E-8) medium (Life Technologies Corporation, 
Carlsbad, CA, USA). The E-8 kit constituted E-8 basal medium and E-8 supplement, serum 
free, to maintain iPSC in undifferentiated state. Media were replenished every 24h. Geltrex 
concentrate was diluted with DMEM/F-12 (Thermo Fisher Scientific,Waltham, MA, 
USA), and stored at -200C; solution was thawed at 40C overnight prior to thawing or sub-
culturing iPSC as per manufacturer’s protocol. Tissue culture treated plates from Corning 
(Corning, NY, USA) were coated with diluted geltrex solution thawed at 4oC overnight 
prior to thawing or sub-culturing iPSC as per manufacturer’s instructions. Cell suspension 
was supplemented with RevitaCellTM (Life Technologies Corporation, Carlsbad, CA, 
USA) post-thaw, for duration of 12h after which media was replaced with regular E-8.  
RevitaCellTM is a combination of Rho Kinase (ROCK) inhibitor and antioxidants to 
enhance post-thaw cellular recovery and survival (Baust et al., 2017). Cells were sub-
cultured at a ratio of 1:4 on day 3 following the previous sub-culture or post-thaw. 
Table 2 illustrates the durations of MS exposure to iPSC after which the cell samples were 
collected for downstream analyses. 
 
Note- The day on which the cells were initially passaged, seeded, and designated to 




exposure, cells were given a duration of 24h to settle and acclimatize to E-8 medium and 
the Geltrex matrix environment after which MS or N exposure was initiated. 
 
2.2. Stock and working concentrations of MS and N 
 
Stock solutions of 100 µM MS and 200 µM N were freshly prepared during every 
sub-culture in E-8 medium with vortexing and a brief 1-minute sonication followed by 
sterilization using 0.2-micron SFCA membrane filter. Working concentration solutions 
were prepared every 24h by serial dilution of stock solutions with E-8. For cells designated 
to be exposed to both MS and N, cells were initially exposed to 10 µM N for 2h followed 
by aspiration and addition of E-8 media to a final concentration of 10 µM MS and 10 µM 




2.3. Cell viability by MTT assay (Mosmann, 1983) 
Approximately 48h after passage, iPSC were treated with MS and N. Treatment 
concentrations 0-, 50-, 100-, 200-, 400- and 800-µM MS and N exposure to iPSC for a 
duration of 24h was used to assess their effects on cell viability. 5 mg/mL MTT reagent 
(Sigma-Aldrich Corp) was added 2h prior to end of exposure period (22ndh) to each well 
(10% v/v) without the removal of respective treatment media and plates were kept in an 
incubator for 2h.  At the end of the exposure period (total exposure time: 24h), treatment 
solutions containing MTT reagent were removed and replaced by spectrophotometric grade 
dimethyl sulfoxide (DMSO; Alfa Aesar, Ward Hill, MA, USA). The plates were then 
shaken for 15 minutes on a reciprocal shaker and absorbance was measured at 550nm using 
Synergy H1 microplate reader (BioTek, Winooski, Vermont, USA).  Cell viability was 
determined by comparing average absorbance readings of respective treatment 
concentrations minus average blank absorbance (DMSO only) to average control 
absorbance readings minus average blank absorbance (DMSO only) and reported as 
percentage viability of control.   
 
2.4. Total Histone Protein Extraction and Quantification 
 
Total histone protein (THP) extraction from 4 X 106 iPSC of MS unexposed and 
exposed cell samples was performed using EpiQuikTM total histone extraction kit 
(Epigentek, Farmingdale, NY, USA), as per manufacturer’s instructions. The histone 
extracts were further diluted using balance buffer and stored at -800C. Diluted THP extracts 
were quantified using the bicinchoninic acid (BCA) protein assay (Thermo Fisher 




2.5. Histone H3 Modification Multiplex Assay 
 
Quantification of 21 genomic H3-PTM was performed using an ELISA-based 
calorimetric assay (Epigentek, Farmingdale, NY, USA). THP extracts from unexposed, 10 
µM MS, 10 µM nicotine, and 1% ethanol exposed iPSC were added to designated wells 
pre-coated with antibodies specific to each H3-PTM and incubated for 1.5h at 370C. Wells 
were washed and incubated with diluted detection antibody for 1h at room temperature.  
Following incubation, wells were sequentially incubated with color developer and stop 
solutions, and the absorbance of the developed color was measured at 450nm using 
Synergy H1 microplate reader (BioTek, Winooski, VT, USA).  The amount of H3-PTM 
was calculated according to the following formula:  
H3-PTM modification (ng/μg) =    (Sample OD- BLANK OD)/ S  
 
where OD is optical density, S is amount of input sample protein (ng), and P is amount of 
input assay control (ng). 
 
 
2.6. Global Histone H3K9 mono-methyl (H3K9me1) and H3K27 tri-methyl 
(H3K27me3) quantification 
 
Quantification of H3K9me1 and H3K27me3 modifications was performed using 
an ELISA-based calorimetric assay (Epigentek, Farmingdale, NY, USA), similar to as 
described in section 2.5. The amount of histone modification was quantified according to 
the following formula: 
 H3K9me1/H3K27me3 (ng/mg protein) =       OD(SAMPLE-BLANK) 
 
(Assay control OD- BLANK OD)/P 




Note- Slope was computed from the change in OD/ng of standard control 
2.7. Characterization of iPSC by Immunocytochemistry 
 
All solutions for immunocytochemistry (ICC) were obtained from Life 
Technologies Corporation (Carlsbad, CA, USA).  iPSC were cultured for 2d and then fixed 
with 4% paraformaldehyde solution for 15 min after which they were permeabilized for 15 
min with permeabilization solution S. Cells were then incubated with blocking solution for 
30mins. Primary antibodies, rabbit anti-OCT4 and mouse anti-SSEA4, were added directly 
to the blocking solution and incubated for 3h, after which cells were washed and incubated 
with secondary antibodies, Alexa-Fluor 594 donkey anti-rabbit for OCT-4, and Alexa-
Fluor 488 goat anti-mouse for SSEA4 for 1h. DNA-binding fluorescent dye 4,6-diamidino-
2-phenylindole (DAPI; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as 
counter stain to detect cell nuclei. The cells were then washed, air-dried and mounted with 
coverslip and imaged with EVOS FL microscope (Figures 3A-3E) (Thermo Fisher 
Scientific, Waltham, MA, USA). 
 
2.8. Flow cytometry analyses - Measuring intra-cellular levels of STAT-3, 
STAT3-pTyr-705, STAT3-pSer-727, OCT4, and TRA-1-60 in iPSC    
 
Cells at required density were condensed into single cell suspensions using 0.48 
mM Gibco® Versene Solution 0.48 mM (Thermo Fisher Scientific, Waltham, MA, USA). 
Cells were re-suspended in stain buffer containing 0.2% BSA and 0.09% sodium azide (BD 
Biosciences, San Jose, CA, USA) and fixed to a final concentration of 2% 
paraformaldehyde for 10min. Following fixation, cells were permeabilized with ice-cold 




fluorochrome-conjugated monoclonal antibody for 30mins in the dark at room 
temperature. Antibodies, Phycoerythrin (PE) conjugated anti-STAT3, Alexa-Fluor 647 
conjugated anti-STAT3-pSer-727, and PE conjugated anti-STAT3-pTyr-705 were 
obtained from BD Biosciences (San Jose, CA, USA); antibodies FITC conjugated anti-
TRA-1-60 and alexa-fluor 647 conjugated anti-OCT4 were procured from Millipore Sigma 
(Burlington, MA, USA). After staining, cells were washed twice with stain buffer and 
ready for flow cytometry (FC) analysis. Appropriate isotype controls were conducted 
simultaneously with each antibody (Figure 4). All samples were run in Luminex 
FlowSight® (Luminex Corporation, Austin, TX, USA) with an acquisition count of 10,000 
events per sample. 
2.9. Real-time quantitative PCR  
 
Total RNA extractions were performed using the RNeasy Mini Kit (Qiagen, 
Germantown, MD, USA) including an on-column DNase digestion using RNase-free 
DNase Set (Qiagen, Germantown, MD, USA).  Extracts were collected and quantified 
using NanoDrop One (Thermo Scientific, Waltham, MA, USA) and stored at -800C. Real 
time quantitative polymerase chain reaction (RT-qPCR) was performed using a two-step 
method; cDNA synthesis from total RNA extracts was performed using SuperScript IV 
VILO master mix (Thermo Fisher Scientific, Waltham, MA, USA) according to the 
manufacturer’s protocol using a Techne TC-412 Thermal Cycler (Vernon Hills, IL, USA).  
RT-qPCR of cDNA templates was performed using Taqman gene expression assays 
(Thermo Scientific, Waltham, MA, USA) in Quant Studio 3 Real-Time PCR system 




relative gene expression method (∆∆Ct).  Threshold cycle (Ct) value of all the target genes 
were normalized using the Ct value 18S rRNA as endogenous control.  
2.10. Statistical and data analysis 
 
All data were analyzed using GraphPad Prism 6.0 (La Jolla, CA, USA). All 
experiments were repeated at least 3 times and performed with at least 2 replicates per 
sample group. One-way or two-way ANOVA followed by Bonferroni’s post-hoc test was 
used to determine statistical significance. Data for genomic H3-PTM were either expressed 
in terms of percent modification relative to control or as time versus quantity of H3-PTM.  
Results for RT-qPCR were calculated by the relative gene expression method 
(∆∆Ct).  The Ct value of all the target genes were normalized using the Ct value 18S rRNA 
as endogenous control using SABiosciences statistical software (Rao et al., 2013). Manual 
gating for all the experiments involving FC analyses was performed with IDEAS software 
(Luminex Corporation, Austin, TX, USA) by identifying single cell populations followed 
by establishing positive (+) and negative (-) gates. Scatter plots for the gating procedure 
were obtained by plotting fluorescence intensity (FI) on X-axis and aspect ratio intensity 
on Y-axis. Negative gate is the single cell region of unstained and isotype control samples 
in the scatter plot representing cell population as FI versus aspect ratio intensity. The FI 
region succeeding the negative gate was labelled positive. In this study, FC data is 
expressed in terms of concentration or time versus percentage cell population in the 









3.1 Cell viability of iPSC exposed to Morphine Sulfate and Naltrexone 
 
 The MTT assay is used to measure the mitochondrial activity of cells, which 
indirectly serves as a measure of cell viability in proportion with changes to mitochondrial 
metabolism. The cell viability of iPSC was unaltered following 24h exposure to various 
concentrations of MS and N (Figure 2) as discussed in section 2.3.  
 
3.2. Suppression of H3K9me1 and H3K27me3 
 
Analyses of 21 genomic H3-PTM (Table 3) following exposure to 10 μM MS for 
2d (Figures 5A-5F) and 5d (Figures 5G-5L) suggest decreased levels of gene expression 
repressive H3-PTM, H3K9me1 (Fig.5C) and H3K27me3 (Fig. 5J). To further understand 
the specificity of MS-induced down-regulation of H3-PTM, we analyzed the changes of 
H3-PTM by exposing 10 μM nicotine (Figures 6A-6F) and 1% ethanol (Figures 6G-6L) to 
iPSC for 5 days. Transcriptionally repressive H3K9me1 and H3K27me3 are predominantly 
associated with heterochromatin. Our data demonstrates suppression of genomic 
H3K9me1 and H3K27me3 with MS exposure but neither with nicotine nor ethanol. 
Interestingly, exposure to nicotine resulted in increased genomic levels of H3K18ac, 
H3ser10P, and H3K79me2 and a decrease in genomic H3ser28P. However, the decrease 
in H3K9me1 (Figure 7A) preceded H3K27me3 (Figure 7B) suggesting MS-mediated 
suppression is linked to the duration of MS exposure. Furthermore, the effect was not 
antagonized by pre-exposure to N but was reversible following a 3d recovery (R) period 




progressive decrease in the genomic levels of both H3K9me1 (Figures 8A-8C) and 
H3K27me3 (Figures 9A-9C) with another increase on day 26 signifying compensatory 
mechanisms in stem cells to stabilize MS-induced chromatin aberrations (Figures 8D and 
9D). These results support the idea that EG insult induced by MS is reversible but neither 
mitotically heritable nor antagonized by N. 
 
3.3. Gene expression disruption of STAT3  
 
Gene expression analyses of 44 genes (Table 4) controlling transcriptional regulatory 
networks in stem cells show an approximate 12-fold transcriptional up-regulation of 
STAT3 mRNA following 2d MS exposure (Figure 10A). Interestingly, STAT3 mRNA 
levels were unchanged following 2d-nicotine and -ethanol exposure, suggesting an MS 
specific STAT3 gene expression perturbation (Figures 10B and 10C). However, the 
transcriptional stimulation started to plunge on day 11 and 20 and were not different from 
control on day 29 (Figure 11; Table 5).  In contrast to the transcriptional stimulation of 
STAT3 gene expression, levels of STAT3 protein were suppressed suggesting translational 
down-regulation. Also, both pre-exposure to N and recovery effectively antagonized and 
reversed the MS-induced effect on STAT3 protein levels, respectively, with 2d and 5d MS 
exposure (Figures 12A-12C). Upon continuous MS exposure, protein levels exhibited 
considerable decrease relative to control on day 2 and day 11 respectively but were not 
different on day 29 (Figure 12D; Table 6). Thus, we conclude that MS targets and disrupts 





3.4. Differences in STAT3-pTyr-705 and STAT3-pSer-727 following MS 
exposure 
 
Phosphorylation at tyrosine-705 residue in STAT3 protein is deemed as pre-requisite for 
nuclear translocation of STAT3 and its consequent genomic transcriptional influence. 
STAT3-pTyr-705 was unchanged after 2d (Figures 13A and 13C), yet down-regulated with 
5d MS exposure (Figures 13B and 13D); downregulation was observed in iPSC exposed 
to 10 μM but not 1 μM MS, and was not antagonized by N. Results obtained from 
prolonged MS exposure show no significant changes in STAT3-pTyr-705 levels relative 
to control on days 2, 11, 20 and 29, respectively (Figure 13E; Table 7). In addition to 
STAT3-pTyr-705, phosphorylation at serine-727 in STAT3 protein is linked to an increase 
in stability and intra-nuclear retention time of previously translocated STAT3 protein.   
Our data demonstrates a statistically significant reduction in STAT3-pSer-727, with 
1 and 10 μM MS on day 2 (Figure 14A and 14C) but not on day 5 (Figures 14B and 14D); 
the MS-induced effect was effectively antagonized in iPSC pre-exposed to N. Furthermore, 
unlike STAT3-pTyr-705, prolonged MS exposure demonstrated significant 
downregulation of STAT3-pSer-727 levels relative to control on days 11 and 20, but not 
on day 29 (Figure 14E; Table 8).   
3.5. MS-induced transcriptional repression of OPRM1, OPRD1, and OPRK1 
 
MS induced down-regulation in OR gene-expression is a well-established phenomenon. 
All 3 OR, OPRM1 (Figure 15A), OPRD1 (Figure 15B) and OPRK1 (Figure 15C), are 
known to be expressed in all types of stem cells. Our data illustrates transcriptional 
downregulation of OR’s in iPSC due to MS exposure. Moreover, the magnitude of 




duration of exposure to MS positively correlated to transcriptional repression of OR up to 
day 20. MS exposed iPSC on day 29, however show no change in OR mRNA levels, except 
for OPRD1, relative to control (Table 9).    
3.6. Effects of MS on stem cell pluripotency expression in iPSC 
 
 OCT4 is a critical nuclear transcription factor protein essential for pluripotency 
maintenance of stem cells. Also, expression of cell surface antigen TRA-1-60 reflects the 
stem cell phenotype in iPSC. Thus, steady or increased expression of these factors 
maintains pluripotency. Shorter durations of MS exposure induced these markers as 
determined by FC analyses of OCT4 (Figure 16A; Table 10) and TRA-1-60 (Figure 16B; 
Table 11) expression in cells. Pluripotency markers stimulation was effectively inhibited 
when iPSC were exposed to 10 μM N prior to MS exposure. However, except for a small 
MS-induced decrease in TRA-1-60 marker following MS exposure on day 29, protein 
levels of both stem cell markers did not significantly differ from control following 
prolonged MS. 
Figure 1. Structure of morphine sulfate pentahydrate. 










Figure 2. Effect of MS and N exposure on viability of iPSC following 24h exposure 
as determined by MTT assay.  
iPSC were cultured for 48h post-passage and then exposed to 50, 100, 200, 400, and 800 
μM of both MS and N for 24h.  Unpaired t test was used to compare groups. Data 


























Figure 3. Expression of pluripotent stem cell specific markers in iPSC as observed 
by immunocytochemistry. 
 (A) Bright field. (B) DAPI. (C) Cell surface marker SSEA4. (D) Nuclear transcription 




































Figure 4. Isotype controls for markers OCT4, SSEA1, STAT3, STAT3-pTyr-705, 































Figure 5.  Effect of 2d and 5d MS exposure on genomic levels of 21 different H3-
PTM.  
Genomic H3-modification ELISA base calorimetric assay following 2 days- (A-F) and 5 
days- (G-L) MS exposure. Two-way ANOVA followed by Bonferroni’s post-hoc test. 
Experiment was performed 3 independent times with 2 replicates. * p<0.05 relative to 
control. Data represented as percent control in mean ± SEM of specific H3-modification 

























































Figure 6.  Effects of 5d nicotine and ethanol exposure on genomic levels of 21 
different H3-PTM.  
Genomic H3-modification ELISA base calorimetric assay following 5d exposure to 
nicotine (A-F) and ethanol (G-L). Two-way ANOVA followed by Bonferroni’s post-hoc 
test. Experiment was performed 3 independent times with 2 replicates. ***p<0.001 relative 
to control.  Data represented as percent control in mean ± SEM of specific H3-



















































Figure 7. Suppression of genomic H3K9me1 and H3K27me3 levels in shorter and 
longer-term culture passages following MS exposure.  
iPSC were collected following 2d and 5d MS exposure for histone protein extraction, and 
extracts were subjected to ELISA based analyses of genomic H3K9me1 and H3K27me3. 
Two-way ANOVA followed by Bonferroni’s post-hoc test. Experiment was performed 3 
independent times with 2 replicates. * p<0.05 relative to control. Data represented as 
percent control in mean ± SEM of specific H3-modification per input mg protein. 
Figures 7A through 7D represent calculated histone modifications (ng/mg of total 
protein), expressed as mean percent control ± SEM of 3 independent experiments, each 
with ≥ 2 replicates. Panels represent ELISA based assays of genomic (A) H3K9me1, (B) 
H3K27me3, (C) H3K9me1 on day 2, and (D) H3K27me3 on day 5. To deduce the pattern 
of MS induced alterations in H3K9me1 and H3K27me3, iPSC were collected during 
every passage, and analyzed similarly on days 8, 11, 14, 17, 20, 23, 26, and 29 
respectively. (E) H3K9me1 and (F) H3K27me3 data are expressed as days in cell culture 
versus quantity of histone modification in ng/mg total protein (representative image from 
3 independent experiments with 3 replicates; * p<0.05 relative to control; two-way 























Figure 8. Effect of chronic MS exposure on genomic levels of H3K9me1.  
iPSC were collected during every passage, and analyzed similarly on days 8, 11, 14, 17, 
20, 23, 26, and 29 respectively. Data are expressed as days in cell culture versus quantity 
of histone modification in ng/mg total protein. Figures 8A, 8B, and 8C show one 
representative independent experiment each (n=1) with 3 biological replicates. Figure 8D 
represents the genomic H3K9me1 data following 8d, 17d, and 29d MS exposure 
compiled from 3 independent experiments; Two-way ANOVA followed by Bonferroni’s 
post-hoc test where *p<0.05,  **p<0.01  and ***p<0.001 relative to control. Data 




























Figure 9. Effect of chronic MS exposure on genomic levels of H3K27me3.  
iPSC were collected during every passage, and analyzed similarly on days 8, 11, 14, 17, 
20, 23, 26, and 29 respectively. Data are expressed as days in cell culture versus quantity 
of histone modification in ng/mg total protein. Figures 9A, 9B, and 9C show one 
independent experiment each (n=1) with 3 biological replicates. Figure 9D represents the 
genomic H3K27me3 data following 8d, 17d, and 29d MS exposure compiled from 3 
independent experiments; Two-way ANOVA followed by Bonferroni’s post-hoc test 



























Figure 10. Volcano plot representing stem cell transcription regulating gene 
expression changes following 2d exposure to (A)MS, (B) nicotine, and (C) ethanol.  
Figures represent mean fold change in gene expressions relative to untreated mRNA 
samples, normalized by 18s rRNA’s mRNA expression. Fold change data was analyzed 
using SAbiosciences statistical software. Experiment was performed 3 independent times 







































































































Figure 11. Gene expression changes of STAT3 gene following continuous MS 
exposure.  
Transcriptional up-regulation (UR) followed by down-regulation (DR) of STAT3 gene as 
determined by qPCR. Data represent up/down-regulation ± SEM of normalized fold 
change mean relative to 18s rRNA mRNA levels followed by one-way ANOVA and 
Tukey’s multiple comparisons post-hoc test. Experiment was performed 3 independent 
times with 3 replicates.   
























Figure 12. Effect of MS on STAT3 protein expression followed by 2d, 5d, and 
continuous exposure as determined by flow cytometry.  
Percentage values obtained post-gating from 3 independent experiments with ≥ 2 
replicates were further analyzed by two-way ANOVA and Bonferroni’s post-hoc test 
where *p<0.05 and ***p<0.001 relative to control. Data represented as %Gated ± SEM. 
(A) FC analysis of STAT3 protein levels in control-, MS exposed-, MS exposed and 
recovered-, pre-exposed to N followed by exposure to equimolar concentrations of MS 
and N -, and naltrexone exposed- iPSC; data expressed as percentage gated, where the 
lower gate limit was applied to the region excluding fluorescent positive population of 
unstained, and isotype control. PE-STAT3-2d (Panel 12B) and PE-STAT3-5d (Panel 
12C). Panel’s 12B and 12C show one representative FC scatter plot of each sample 
following 2- and 5-days MS exposure respectively.  (D) FC analyses of changes in 
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Figure 13. MS induced suppression in levels of STAT3-pTyr-705.  
Figures A and B show FC mediated analysis of STAT3 protein levels from control-, MS 
exposed-, MS exposed and recovered-, pre-exposed to N followed by exposure to 
equimolar concentrations of MS and N-, and N exposed- samples of iPSC. Two-way 
ANOVA followed by Bonferroni’s post-hoc test. Experiment was performed 3 
independent times with 3 replicates. *p<0.05, **p<0.01, and ***p<0.001 relative to control. 
Data represented as %Gated ± SEM. (A) STAT3-pTyr-705, 2d MS exposure (B) STAT3-
pTyr-705, 5d MS exposure. PE-STAT3-pSer-727-2d (Panel 13C) and PE-647-STAT3-
pSer-727-5d (Panel 13D). Panel’s 13C and 13D show one representative FC scatter plot 
of each sample following 2- and 5-day MS exposure, respectively. FC aided pattern 
analyses of changes in phosphorylated protein levels of STAT3-pSer-727 (E) protein 
levels on days 2, 11, 20 and 29, respectively. Experiment was performed 3 independent 
times with 3 replicates.; two-way ANOVA followed by Bonferroni’s post-hoc test was 
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Figure 14. MS induced suppression in levels of STAT3-pSer-727.  
Figures A and B show FC mediated analysis of STAT3 protein levels from control-, MS 
exposed-, MS exposed and recovered- (R), pre-exposed to N followed by exposure to 
equimolar concentrations of MS and N-, and N exposed- samples of iPSC.  
Two-way ANOVA followed by Bonferroni’s post-hoc test. Experiment was performed 3 
independent times with 3 replicates. **p<0.01, and ***p<0.001 relative to control. Data 
represented as %Gated ± SEM. (A) STAT3-pSer-727, 2d MS exposure (B) STAT3-pSer-
727, 5d MS exposure. AlexaFluor-647-STAT3-pSer-727-2d (Panel 14C) and AlexaFluor-
647-STAT3-pSer-727-5d (Panel 14D). Panel’s 14C and 14D show one representative FC 
scatter plot of each sample following 2- and 5-day MS exposure, respectively. FC aided 
pattern analyses of changes in phosphorylated protein levels of STAT3-pSer-727 (E) 
protein levels on days 2, 11, 20 and 29, respectively. Experiment was performed 3 
independent times with 3 replicates. *p<0.05, **p<0.01, and ***p<0.001 relative to control; 
two-way ANOVA followed by Bonferroni’s post-hoc test was used for statistical 
analyses (Refer table 8).   
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Figure 15. Opioid receptor genes expression changes following continuous exposure 
of MS to iPSC. Genes (A) OPRM1, (B) OPRD1, and (C) OPRK1.  
OPRM1 demonstrated highest suppression in mRNA level following MS exposure.  
Transcriptional down-regulation followed by up-regulation of ORs genes as determined 
by RT-qPCR. Experiment was performed 3 independent times with 3 replicates. Data 
represent up/down-regulation ± SEM of normalized fold change mean relative to 18s 
rRNA, mRNA levels, followed by one-way ANOVA and Tukey’s multiple comparisons 









































Figure 16. Effects of MS exposure on levels of pluripotency markers in iPSC.  
FC analyses of changes in (A) OCT4, (B) and TRA-1-60 protein levels on days 2, 11, 20, 
and 29 respectively. Two-way ANOVA followed by Bonferroni’s post-hoc test was used 
for statistical analyses. Experiment was performed 3 independent times with 3 replicates. 













Table 1. Opiates,opioids, and their classification with respective compounds in each 
class. 
   
Category Compound 






Natural Endogenous Opioids -endorphin 
Enkephelin 
Dynorphin 
























Table 2. Durations of MS exposure to iPSC after which the cell samples were 
collected for downstream analyses. 
 
Target measured- Method Days in culture with MS exposure 
followed by cell sample collection 
for these days listed 
H3K9me1-ELISA 2;8;11;14;17;20;23;26;29 
H3K27me3-ELISA 2;5;8;11;14;17;20;23;26;29 
Levels of STAT3; STAT3-pSer-
727; STAT3-pTyr-705- FC 
2;11;20;29 
Gene expression analyses of 44 
stem cell transcription regulation 
genes and OPRM1, OPRD1, 
OPRK1, and STAT3- RT-qPCR 
2;11;20;29 


















Table 3. H3-PTMs measured using ELISA-based multiplex assay, following 
exposure to MS, nicotine and ethanol in iPSC. UR: up-regulation; DR: down-
regulation. 
 








Total H3 - - - - 
H3K9ac - - - - 
H3K14ac - - - - 
H3K18ac - - UR - 
H3K56ac - - - - 
H3ser10P - - UR - 
H3ser28P - - DR - 
H3K4me1 - - - - 
H3K4me2 - - - - 
H3K4me3 - - - - 
H3K9me1 DR - - - 
H3K9me2 - - - - 
H3K9me3 - - - - 
H3K27me1 - - - - 
H3K27me2 - - - - 
H3K27me3 - DR - - 
H3K36me1 - - - - 
H3K36me2 - - - - 
H3K36me3 - - - - 
H3K79me1 - - - - 
H3K79me2 - - UR - 












Table 4. Stem cell transcriptional regulatory network genes whose expression 
changes were measured using RT-qPCR, following exposure to MS, nicotine, and 




Gene Function of the protein encoded by 
corresponding gene: 
Reference 
A01               18S Endogenous control (Kuchipudi et 
al., 2012) 
A02               GAPDH Endogenous control (Toegel et al., 
2007) 
A03               HPRT1 Endogenous control (Fu et al., 2009) 
A04               GUSB Endogenous control (Gubern et al., 
2009) 
A05               CALB1 Member of the calcium-binding protein 
superfamily that includes calmodulin and 
troponin  
(O. Li et al., 
2007) 
A06               CDX2 Regulates early embryonic development of 
intestinal tract 
(Bernardo et al., 
2011) 
B01               CDYL Reader protein of H3K9- and H3K27- 
methylation marks  (Escamilla-Del-Arenal et 
al., 2013)(Escamilla-Del-Arenal et al., 2013) 
(Mulligan et al., 
2008) 
B02               EOMES Transcription factor crucial for development 
of embryonic mesoderm and CNS in 
vertebrates (Pfeiffer et al., 2018)(Pfeiffer et 
al., 2018)  
(Pfeiffer et al., 
2018) 
B03               ESX1 Participates in transcriptional regulatory 




B04               FOXC1 Encodes protein that binds to specific regions 
of DNA and modulate the activities of other 
genes 
(Berry et al., 
2006) 
B05               FOXD3 Maintenance of mammalian embryonic stem 
cell pluripotency and regulation of Nanog 
signaling pathway 
(Guo et al., 
2002) 
B06               GATA4 Regulates genes involved in embryogenesis 
and myocardial differentiation 
(Shi et al., 2017) 
C01               GATA6 Family of zinc finger transcription factors 
involved in regulation of cellular 
differentiation and organogenesis 
(Guye et al., 
2016) 
C02               GBX2 Involved in neural crest differentiation and 
dopaminergic neurogenesis 
(Chapman et al., 
1997) 
C03               GJD2 Gap junction protein forming gap junction 
inter-cellular channel 
(Green et al., 
2018) 
C04               GRIN1 A critical subunit of N-methyl-D-aspartate 
receptors essential in formation of synaptic 
plasticity critical for memory and learning 
processes 
(Cantley et al., 
2018) 
C05               GSX2 Significant role in development of 
telencephalic region of the brain 





C06               HAND1 Member of helix-loop-helix family of 
transcription factor; participate in cardiac 
morphogenesis 
(Fujita et al., 
2019) 
D01               HESX1 Transcription factor involved in regulation 
and coordination of early embryonic 
development 
(Pozzi et al., 
2019) 
D02               HNF4A Nuclear transcription factor which binds 
DNA as a homodimer; controls the 
expression of several genes, including 
hepatocyte nuclear factor 1 alpha, a 
transcription factor which regulates the 
expression of several hepatic genes 
(Ng et al., 2019) 
D03               HOXB1 Transcription factor involved in 
morphogenesis in all multicellular organisms 
(Zhou et al., 
2019) 
D04               ISL1 DNA-binding transcriptional activator; 
recognizes and binds to the consensus 
octamer binding site 5'-ATAATTAA-3' in 
promoter of target genes 
(Xiang et al., 
2018) 
D05               JARID2 Regulation of histone methyltransferase 
complex recruitment essential for embryonic 
development 
(Landeira et al., 
2010) 
D06               LHX5 regulation of neuronal differentiation and 
migration during development of the central 
nervous system 
(Sigova et al., 
2013) 
E01               MEIS1 Homeobox protein belonging to the TALE 
('three amino acid loop extension') family of 
homeodomain-containing proteins; required 
for hematopoiesis, megakaryocyte lineage 
development and vascular patterning 
(H. Wang et al., 
2018) 
E02               MYF5 Transcriptional activation of muscle-specific 
target genes and their differentiation 
(J. Wu et al., 
2016) 
E03               MYST3 The protein is composed of a nuclear 
localization domain, a double C2H2 zinc 
finger domain that binds to acetylated histone 
tails, a histone acetyl-transferase domain, a 
glutamate/aspartate-rich region, and a serine- 
and methionine-rich transactivation domain 
(Y.-C. Wang et 
al., 2015) 
E04               NANOG Transcriptional activation and repression 
involved in regulation of embryonic stem 
cells and inner cell mass; regulation of 
SMAD transcriptional complexes 
(Z. Wang et al., 
2012) 
E05               NEUROD1 Acts as a transcriptional activator mediating 
transcriptional activation by binding to E 




E06               NEUROG1 Transcription factor essential for neuronal 
differentiation 
(Boisvert et al., 
2015) 





F02               OTX1 Essential role in embryonic brain and sense 
organs development 
(Larsen et al., 
2010) 
F03               PAX6 Transcription factors essential for 
maintenance cell functions at embryonic 
stage, and development of brain, spinal cord 
and pancreas 
(X. Zhang et al., 
2010) 
F04               POU5F1 Transcription factor that forms a trimeric 
complex with SOX2 on DNA and controls 
the expression of a genes essential for early 
embryogenesis and for embryonic stem cell 
pluripotency 
(Gao et al., 
2013) 
F05               REST Transcriptional repression of neuronal genes 
in non-neuronal tissues 
(Charbord et al., 
2013) 
F06               RFX4 Transcriptional factor rendering 
transcriptional activation and essential for 
early brain development 
(La Manno et 
al., 2016) 
G01               RIF1 Participates in DNA repair mechanisms (Dan et al., 
2014) 
G02               SALL1 Transcription factors essential for embryonic 
development 
(J. Yang et al., 
2010) 
G03               SET Inhibition of histone acetylases, particularly 
to histone H4 causing transcriptional 
repression 
(Kaliman et al., 
2014) 
G04               SIX3 Transcription factor essential for 
development of forebrain and eyes 
(Lavado & 
Oliver, 2011) 




G06               SMARCAD1 Transcription factor promoting transcription 
initiation of several genes 
(Xiao et al., 
2017) 
H01               SOX2 Essential role in formation of several tissues 
and organs during embryonic development 
(Pevny & 
Nicolis, 2010) 
H02               STAT3 Refer introduction Refer 
introduction 
H03               TCF7L1 Essential for terminal differentiation of 
epidermal cells and involved in WNT 
signaling pathway 
(Sierra et al., 
2018) 
H04               TRIM24 Protein localizes in the nucleus and interacts 
with nuclear receptor signaling 
(L.-H. Zhang et 
al., 2015) 
H05               ZFHX3 Transcriptional modulator regulating 
myogenic and neuronal differentiation 
(D. Weber et al., 
2015) 
H06               ZIC3 Transcriptional activator involved in 
embryonic left-right body axis formation 












Table 5. Statistical analysis of STAT3 gene expression following 2, 11, 20, and 29d 
MS exposure. 
 
GENE TWO-WAY ANOVA 
Bonferroni post tests (d vs d) 
Statistical significance- 
Concentration of MS(μM), 
P value 
STAT-3 2d vs 11d 
2d vs 20d 
2d vs 29d 
11d vs 20d 
11d vs 29d 
20d vs 29d 
1, P<0.001;10, P<0.001 
1, P<0.001;10, P<0.001 







































Table 6. Statistical analysis of STAT3 protein levels following 2, 11, 20, and 29d MS 
exposure. 
 
MARKER DAY TWO-WAY ANOVA 




STAT3 2d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











11d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











20d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











29d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 


















Table 7. Statistical analysis of STAT3-pTyr-705 protein levels following 2, 11, 20, 
and 29d MS exposure. 
 
MARKER DAY TWO-WAY ANOVA 






2d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











11d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











20d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











29d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 

















Table 8. Statistical analysis of STAT3-pSer-727 protein levels following 2, 11, 20, 
and 29d MS exposure. 
 
MARKER DAY TWO-WAY ANOVA 






2d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











11d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











20d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











29d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 

















Table 9. Statistical analysis of OPRMI, OPRD1, and OPRK1 gene expressions 
following 2, 11, 20, and 29d MS exposure. 
 
GENE ONE-WAY ANOVA 
Bonferroni post tests (d vs d) 
Statistical significance- 
Concentration of MS(μM), P value 
OPRM1 2d vs 11d 
2d vs 20d 
2d vs 29d 
11d vs 20d 
11d vs 29d 
20d vs 29d 
1, P<0.001;10, P<0.001 
1, P<0.05;10, P<0.001 
ns 
1, P<0.001;10, P<0.01 
1, P<0.001;10, P<0.001 
10, P<0.001 
OPRD1 2d vs 11d 
2d vs 20d 
2d vs 29d 
11d vs 20d 
11d vs 29d 
20d vs 29d 
10, P<0.001 
1, P<0.05;10, P<0.001 
1, P<0.001;10, P<0.01 
1, P<0.01;10, P<0.05 
1.P<0.001, P<0.001 
10, P<0.001 
OPRK1 2d vs 11d 
2d vs 20d 
2d vs 29d 
11d vs 20d 
11d vs 29d 

































Table 10. Statistical analysis of OCT4 protein levels following 2, 11, 20, and 29d MS 
exposure. 
 
MARKER DAY TWO-WAY ANOVA 




OCT-4 2d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











11d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











20d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











29d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 

















Table 11. Statistical analysis of TRA-1-60 protein levels following 2, 11, 20, and 29d 
MS exposure. 
 
MARKER DAY TWO-WAY ANOVA 




TRA-1-60 2d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











11d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











20d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 











29d C vs 1 μM MS  
C vs 10 μM MS 
C vs 10 μM N 
C vs 10 μM MS + 10 μM N 
1 μM MS vs 10 μM MS 
1 μM MS vs 10 μM N 
1 μM MS vs 10 μM MS + 10 μM N 
10 μM MS vs 10 μM N 
10 μM MS vs 10 μM MS + 10 μM N 


















Biomarkers, once validated, can serve as correlations to illicit drug use, addiction, 
and their relative prognosis (Chintalapati & Barile, 2019). Until recently, a majority of 
studies have focused on opioid-induced EG changes related to malformations in neuronal 
circuitry (Browne et al., 2020; Farris et al., 2015; Heller et al., 2016; Kenny, 2014). 
Consequently there has been limited attention to the EG mechanisms at the cellular level 
following opioid exposure (Liang et al., 2013; Oertel et al., 2012; Wachman et al., 2014). 
In this study, human-iPSC were used to study changes in genomic H3-PTM following 
prolonged periods of MS exposure.  The data demonstrate a decrease in genomic 
H3K9me1 and H3K27me3 levels which was not antagonized by N. Interestingly, levels 
of transcriptionally repressive genomic H3K9me1 and H3K27me3 decrease over time 
followed by a rise, suggesting an initial accumulation of these modifications in 
chromatin. This is then shadowed by innate compensatory repair mechanisms or acquired 
resistance to continuous MS exposure in vitro. In addition, recovery with regular media 
post-MS exposure shifted H3-PTM levels to that of control effectively demonstrating the 
ability of iPSC to recover from MS-mediated EG insult. Studies examining EG effects of 
nicotine and ethanol are limited, but indicate that nicotine promotes acetylation of H3 and 
H4 HP, creating a transcriptionally permissive chromatin environment. Nicotine exposure 
to mouse primary cortical neuronal culture and lymphocyte culture resulted in decreased 
genomic levels of transcriptionally repressive H3K9me2 (Chase & Sharma, 2013). Our 
study demonstrates an increase in genomic levels of H3K18ac, H3ser10P, and 
H3K79me2 and concurrent decrease in H3ser28P following 5d nicotine exposure. Further 




regions is necessary to understand the biological significance of nicotine induced H3-
PTM. 
For stem cells to maintain a defined pluripotent state, it is necessary for controlled 
expression of genes involved in regulation of the transcriptional regulatory network in 
iPSC (Kunarso et al., 2010; Neph et al., 2012). STAT3, an acute phase response factor, is 
considered a key biological regulator of cellular proliferation, survival, and angiogenesis 
(Haghikia et al., 2014; Siveen et al., 2014).   Expression array analyses of genes involved 
in transcription regulatory network in stem cells revealed an initial transcription up-
regulation followed by subsequent downregulation of STAT3 gene. Furthermore, 
phosphorylation of STAT3 is essential for its activation, and intrinsic biological activity. 
Evidence exists that nuclear translocation of STAT3 can occur despite its 
phosphorylation (Haghikia et al., 2014; Siveen et al., 2014; Yu et al., 2014). Previous 
studies have demonstrated that MS causes STAT3 activation and phosphorylation in 
mouse retinal endothelial cells and mesangial cells via OPRK1 receptors (Weber et al., 
2013). 
Our data demonstrate an inverse relationship between STAT3 transcription and 
translation with MS exposure for shorter durations; continuous exposure to MS however, 
resulted in a shift of both transcription and translation relative to control. Hence, STAT3 
gene expression disruption occurs via distinct alterations to transcription and translation. 
These findings were further bolstered by observing the levels of STAT3-pTyr-705 and 
STAT3-pSer-727; namely -pTyr-705 was down-regulated with 5d MS exposure while -
pSer-727 was suppressed with 2d MS exposure suggesting the influence of duration of 




protein levels of STAT3, STAT3-pTyr-705 and -pSer-727 were not different from control 
following 3d recovery. Also, exposing cells to N prior to MS exposure reversed the MS-
induced down-regulation of STAT3 and its phosphorylated forms, suggesting an OR-
mediated effect.    
OR genes OPRM1, OPRD1 and OPRK1 are expressed in all types of stem cells 
and their stimulation by endogenous and exogenous ligands is linked to several sub-
cellular alterations (Carlo et al., 2003; Narita et al., 2006). Our results support down-
regulation in mRNA levels of OR’s. Moreover, the suppression of OPRM1 mRNA was 
identified as most pronounced following MS exposure, compared to OPRD1, and 
OPRK1. However, suppression in ORs mRNA was more evident during early durations 
of MS exposure, followed by subsequent equalization in ORs mRNA levels to that of 
control. These results demonstrate that MS induced transcriptional suppression of ORs is 
related to both duration of exposure and concentration of MS.  It is reasonable to apply 
these results to mimic the differences in clinical applications of opioids, depending on 
whether the drugs are used for short-term pain relief or longer-term dependency. 
Non-differentiation and continual maintenance of pluripotency phenotype are 
critical to ensure survival and perpetuation of iPSC (Humphrey et al., 2004; James et al., 
2005). Previous studies in our lab involving mES cells exposed to MS caused inhibition 
of neuronal differentiation via mu-opioid receptor activation (Dholakiya et al., 2016). In 
our current study, we observed MS-induced stimulation of pluripotency markers in iPSC 
with 2d and 11d MS exposure. The level of stem cell nuclear transcription factor OCT4 
was lower but statistically insignificant from control on day 20 and not different from 




exposure followed by a continuous decrease on days 11, 20, and 29 respectively, 
suggesting an apparent stimulation (or maintenance) of stem cell phenotype with shorter 
duration of MS exposure and  reversing for longer durations. Interestingly, levels of 
observed markers were effectively blocked by pre-treating cells with N, signifying an 
OR-dependent pluripotent perturbation.  
In conclusion, our study addresses the plausible potential of opioids to cause 
aberrations in EG H3-PTM and gene expression perturbations of STAT3 in iPSC in vitro. 
The genotypic and phenotypic characteristics of iPSC involving substantial EG 
reprogramming with dynamic chromatin remodeling guiding their ability to differentiate 
into any cells of the three embryonic layers―ectoderm, endoderm and 
mesoderm―render them ideal for EG mechanistic studies (Goodnight et al., 2019; Ming-
Tao et al., 2017). Interestingly, all sub-cellular effects identified in this study were not 
different from that of control following recovery, and in general, during prolonged 
periods of MS exposure, portending innate molecular compensatory repair mechanisms 
in iPSC that are yet to be delineated. Future studies may concentrate on mechanistic 
correlations between opioid receptor pathways and MS induced EG perturbations, and 
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